Literature DB >> 26921537

Aquaporin-2 is a potential biomarker for tolvaptan efficacy in decompensated heart failure complicated by diabetic nephrotic syndrome.

Atsushi Tanaka1, Tsukasa Nakamura2, Eiichi Sato2, Koichi Node3.   

Abstract

Entities:  

Keywords:  Aquaporin-2; Diabetic nephropathy; Heart failure; Tolvaptan

Mesh：

Substances：

Year:  2016        PMID： 26921537     DOI： 10.1016/j.ijcard.2016.02.106

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  3 in total

1.  Expression of aquaporin-2 in the collecting duct and responses to tolvaptan.

Authors:  Kota Kakeshita; Tsutomu Koike; Teruhiko Imamura; Hayato Fujioka; Hidenori Yamazaki; Koichiro Kinugawa
Journal:  CEN Case Rep       Date:  2020-08-10

2.  Different Effects of Tolvaptan in Patients with Idiopathic Membranous Nephropathy with Nephrotic Syndrome.

Authors:  Atsushi Tanaka; Tsukasa Nakamura; Eiichi Sato; Yoshihiko Ueda; Koichi Node
Journal:  Intern Med       Date:  2017-01-15       Impact factor: 1.271

3.  The effect of tolvaptan on renal excretion of electrolytes and urea nitrogen in patients undergoing coronary artery bypass surgery.

Authors:  Tomoko S Kato; Hiroshi Nakamura; Mai Murata; Kishio Kuroda; Hitoshi Suzuki; Yasutaka Yokoyama; Akie Shimada; Satoshi Matsushita; Taira Yamamoto; Atsushi Amano
Journal:  BMC Cardiovasc Disord       Date:  2016-09-13       Impact factor: 2.298
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.